Pharmacokinetic and pharmacodynamic alterations of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors: Drug–drug interactions and interindividual differences in transporter and metabolic enzyme functions

西伐他汀 氟伐他汀 药理学 阿托伐他汀 药代动力学 普伐他汀 瑞舒伐他汀 皮塔伐他汀 羟甲基戊二酰辅酶A还原酶 他汀类 HMG-CoA还原酶 化学 CYP3A4型 药物相互作用 辛伐他汀 还原酶 医学 胆固醇 细胞色素P450 新陈代谢 生物化学
作者
Yoshihisa Shitara,Yuichi Sugiyama
出处
期刊:Pharmacology & Therapeutics [Elsevier BV]
卷期号:112 (1): 71-105 被引量:566
标识
DOI:10.1016/j.pharmthera.2006.03.003
摘要

3-Hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors (statins) are widely used for the treatment of hypercholesterolemia. Their efficacy in preventing cardiovascular events has been shown by a large number of clinical trials. However, myotoxic side effects, sometimes severe, including myopathy or rhabdomyolysis, are associated with the use of statins. In some cases, such toxicity is associated with pharmacokinetic alterations. In this review, the pharmacokinetic aspects and physicochemical properties of statins are reviewed in order to understand the mechanism governing their pharmacokinetic alterations. Among the statins, simvastatin, lovastatin and atorvastatin are metabolized by cytochrome P450 3A4 (CYP3A4) while fluvastatin is metabolized by CYP2C9. Cerivastatin is subjected to 2 metabolic pathways mediated by CYP2C8 and 3A4. Pravastatin, rosuvastatin and pitavastatin undergo little metabolism. Their plasma clearances are governed by the transporters involved in the hepatic uptake and biliary excretion. Also for other statins, which are orally administered as open acid forms (i.e. fluvastatin, cerivastatin and atorvastatin), hepatic uptake transporter(s) play important roles in their clearances. Based on such information, pharmacokinetic alterations of statins can be predicted following coadministration of other drugs or in patients with lowered activities in drug metabolism and/or transport. We also present a quantitative analysis of the effect of some factors on the pharmacokinetics of statins based on a physiologically based pharmacokinetic model. To avoid a pharmacokinetic alteration, we need to have information about the metabolizing enzyme(s) and transporter(s) involved in the pharmacokinetics of statins and, along with such information, model-based prediction is also useful.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
夜神月发布了新的文献求助10
刚刚
stephenzh完成签到,获得积分10
2秒前
精明黄蜂完成签到 ,获得积分10
3秒前
机智的阿振完成签到,获得积分10
4秒前
吴律完成签到,获得积分10
5秒前
小潘完成签到 ,获得积分10
7秒前
哈哈完成签到 ,获得积分10
8秒前
one完成签到 ,获得积分10
13秒前
冷如松发布了新的文献求助20
13秒前
17秒前
CodeCraft应助科研通管家采纳,获得10
21秒前
布蓝图完成签到 ,获得积分10
22秒前
NexusExplorer应助科研通管家采纳,获得10
22秒前
22秒前
Summer完成签到 ,获得积分10
23秒前
鸭鸭完成签到 ,获得积分10
24秒前
冷如松完成签到,获得积分10
24秒前
25秒前
科研通AI5应助野椒搞科研采纳,获得30
25秒前
coolru完成签到,获得积分10
28秒前
fyy完成签到 ,获得积分10
29秒前
30秒前
朱光辉完成签到,获得积分10
32秒前
夜神月完成签到,获得积分10
34秒前
35秒前
LYH完成签到,获得积分10
35秒前
凡人完成签到 ,获得积分10
35秒前
xujingyi发布了新的文献求助10
39秒前
lemon完成签到 ,获得积分10
40秒前
kyt完成签到,获得积分10
41秒前
负责的寒梅完成签到 ,获得积分10
43秒前
沫荔完成签到 ,获得积分10
43秒前
wanghao完成签到 ,获得积分10
44秒前
李海平完成签到 ,获得积分10
45秒前
聪慧的从雪完成签到 ,获得积分10
49秒前
安详的语蕊完成签到,获得积分10
52秒前
淡然的剑通完成签到 ,获得积分10
53秒前
Holly完成签到,获得积分10
55秒前
科研王子完成签到,获得积分10
55秒前
宇文雨文给宇文雨文的求助进行了留言
57秒前
高分求助中
Pipeline and riser loss of containment 2001 - 2020 (PARLOC 2020) 1000
哈工大泛函分析教案课件、“72小时速成泛函分析:从入门到入土.PDF”等 660
Comparing natural with chemical additive production 500
The Leucovorin Guide for Parents: Understanding Autism’s Folate 500
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 500
A Manual for the Identification of Plant Seeds and Fruits : Second revised edition 500
The Social Work Ethics Casebook: Cases and Commentary (revised 2nd ed.) 400
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 内科学 生物化学 物理 计算机科学 纳米技术 遗传学 基因 复合材料 化学工程 物理化学 病理 催化作用 免疫学 量子力学
热门帖子
关注 科研通微信公众号,转发送积分 5212420
求助须知:如何正确求助?哪些是违规求助? 4388601
关于积分的说明 13664165
捐赠科研通 4249133
什么是DOI,文献DOI怎么找? 2331417
邀请新用户注册赠送积分活动 1329109
关于科研通互助平台的介绍 1282517